Cargando…

Population serology for SARS-CoV-2 is essential to regional and global preparedness

Detalles Bibliográficos
Autores principales:	Tian, Huaiyu, Bjornstad, Ottar N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832696/ https://www.ncbi.nlm.nih.gov/pubmed/33521710 http://dx.doi.org/10.1016/S2666-5247(20)30055-0

Ejemplares similares

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response
Publicado: (2023)

Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic
por: Wang, Jigang, et al.
Publicado: (2020)

Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings
por: Kucharski, Adam J, et al.
Publicado: (2020)

Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling
por: Khan, Sakirul, et al.
Publicado: (2022)

Will COVID-19 generate global preparedness?
por: Jacobsen, Kathryn H
Publicado: (2020)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2
por: Strugnell, Richard, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Nowcasting towards sustainable SARS-CoV-2 endemicity
por: Leung, Gabriel M
Publicado: (2021)

Addendum: competing interests and the origins of SARS-CoV-2
por: Editors of The Lancet
Publicado: (2021)

Escalating burden of SARS-CoV-2 infection in Ethiopia
por: Adane, Kelemework, et al.
Publicado: (2021)

Spreading of SARS-CoV-2 from hamsters to humans
por: Haagmans, Bart L, et al.
Publicado: (2022)

Assessing the potential for fomite transmission of SARS-CoV-2
por: Short, Kirsty R, et al.
Publicado: (2023)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqjn30tu88b7e88c448iockd3k